Reithmann C, Hallström S, Pilz G, Kapsner T, Schlag G, Werdan K
Department of Medicine, Klinikum Grosshadern, University of Munich, Germany.
Circ Shock. 1993 Sep;41(1):48-59.
The purpose of this study was to test the possibility that the mechanisms of catecholamine-induced desensitization of cardiac beta-adrenoceptor stimulation are modified in septic shock. Exposure of neonatal rat cardiomyocytes for 48 hr to plasma of noradrenaline-treated patients with septic shock led to a down-regulation of beta-adrenoceptors by 35%, an increase in the level of inhibitory G protein alpha-subunits by 60%, and a decrease in isoproterenol-stimulated adenylyl cyclase activity by 50% in membranes prepared from the rat cardiomyocytes. Similar alterations were observed following pretreatment of the cells with plasma of adrenaline-treated patients with cardiogenic shock. In contrast, exposure of the cardiomyocytes to plasma of intensive care patients without shock, and to plasma of dopamine-treated patients with septic shock did not induce alterations of the cardiomyocyte adenylyl cyclase system. The dosage of the catecholamines had to be increased within the first two days of treatment in the noradrenaline-treated patients, but not in the dopamine-treated patients with septic shock. Thus, this observed tolerance to noradrenaline in the treatment of septic shock may, in part, be due to a desensitization of cardiac beta-adrenoceptor stimulation induced by the beta-adrenoceptor stimulatory effect of noradrenaline.
本研究的目的是检验在感染性休克中,儿茶酚胺诱导的心脏β-肾上腺素能受体刺激脱敏机制是否发生改变。将新生大鼠心肌细胞暴露于去甲肾上腺素治疗的感染性休克患者的血浆中48小时,导致大鼠心肌细胞膜中β-肾上腺素能受体下调35%,抑制性G蛋白α亚基水平增加60%,异丙肾上腺素刺激的腺苷酸环化酶活性降低50%。在用肾上腺素治疗的心源性休克患者的血浆预处理细胞后,观察到类似的变化。相比之下,将心肌细胞暴露于无休克的重症监护患者的血浆以及多巴胺治疗的感染性休克患者的血浆中,并未诱导心肌细胞腺苷酸环化酶系统的改变。去甲肾上腺素治疗的患者在治疗的前两天内必须增加儿茶酚胺的剂量,但多巴胺治疗的感染性休克患者则无需增加。因此,在感染性休克治疗中观察到的对去甲肾上腺素的耐受性,可能部分归因于去甲肾上腺素的β-肾上腺素能受体刺激作用所诱导的心脏β-肾上腺素能受体刺激脱敏。